1,448
Views
41
CrossRef citations to date
0
Altmetric
Reviews

Russian vaccines against especially dangerous bacterial pathogens

, , &
Pages 1-17 | Received 23 Sep 2015, Accepted 02 Nov 2015, Published online: 25 Jan 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Hien Van Doan, Seyed Hossein Hoseinifar, Einar Ringø, Maria Ángeles Esteban, Maryam Dadar, Mahmoud A. O. Dawood & Caterina Faggio. (2020) Host-Associated Probiotics: A Key Factor in Sustainable Aquaculture. Reviews in Fisheries Science & Aquaculture 28:1, pages 16-42.
Read now
Olga A. Kondakova, Nikolai A. Nikitin, Ekaterina A. Evtushenko, Ekaterina M. Ryabchevskaya, Joseph G. Atabekov & Olga V. Karpova. (2019) Vaccines against anthrax based on recombinant protective antigen: problems and solutions. Expert Review of Vaccines 18:8, pages 813-828.
Read now
Janice Longstreth, Mario H. Skiadopoulos & Robert J. Hopkins. (2016) Licensure strategy for pre- and post-exposure prophylaxis of biothrax vaccine: the first vaccine licensed using the FDA animal rule. Expert Review of Vaccines 15:12, pages 1467-1479.
Read now
Karen L. Elkins, Sherry L. Kurtz & Roberto De Pascalis. (2016) Progress, challenges, and opportunities in Francisella vaccine development. Expert Review of Vaccines 15:9, pages 1183-1196.
Read now
Sophie A. Aschenbroich, Eric R. Lafontaine & Robert J. Hogan. (2016) Melioidosis and glanders modulation of the innate immune system: barriers to current and future vaccine approaches. Expert Review of Vaccines 15:9, pages 1163-1181.
Read now

Articles from other publishers (36)

David L. Saunders, Benjamin C. Pierson, Oksana Zlenko & H. Carl Gelhaus. (2024) Considerations for prevention of and emergency response to tularemia outbreaks in Ukraine: vaccine involvement. Frontiers in Bacteriology 3.
Crossref
O. A. Trunova, L. V. Skrypka, A. E. Bagriy, E. V. Prochorov & N. A. Reznichenko. (2023) Immunological and epidemiological effectiveness of tularemia vaccination in the Donbass region. Medical Herald of the South of Russia 14:4, pages 66-76.
Crossref
Elizabeth Crawford, Adam Bobrow, Landy Sun, Sridevi Joshi, Viji Vijayan, Stuart Blacksell, Gautham Venugopalan & Nicole Tensmeyer. (2023) Cyberbiosecurity in high-containment laboratories. Frontiers in Bioengineering and Biotechnology 11.
Crossref
John W. Kindt Jr, Nazmul Kazi, Indika Kahanda, Christopher da Costa, Robert Carnahan, Brenda A. Wilson, Hugh Mason & S. Indu Rupassara. 2023. New Topics in Vaccine Development [Working Title]. New Topics in Vaccine Development [Working Title].
Roberto Biselli, Roberto Nisini, Florigio Lista, Alberto Autore, Marco Lastilla, Giuseppe De Lorenzo, Mario Stefano Peragallo, Tommaso Stroffolini & Raffaele D’Amelio. (2022) A Historical Review of Military Medical Strategies for Fighting Infectious Diseases: From Battlefields to Global Health. Biomedicines 10:8, pages 2050.
Crossref
S. V. Dentovskaya, A. S. Trunyakova, A. S. Vagaiskaya, M. E. Platonov, E. A. Tyurin & A. P. Anisimov. (2022) Concerning Criteria for transfer of Attenuated Yersinia pestis strains from Pathogenicity (Hazard) Group I into Pathogenicity Group III. Problems of Particularly Dangerous Infections:2, pages 20-26.
Crossref
Tauseef Ahmad, Mukhtiar Baig, Sahar Shafik Othman, Husam Malibary, Shabir Ahmad, Syed Majid Rasheed, Mohammad T. Al Bataineh & Basem Al-Omari. (2022) Bibliometric Analysis and Visualization Mapping of Anthrax Vaccine Publications from 1991 through 2021. Vaccines 10:7, pages 1007.
Crossref
Wei Zhang, Xiaolin Song, Lina Zhai, Jianshu Guo, Xinying Zheng, Lili Zhang, Meng Lv, Lingfei Hu, Dongsheng Zhou, Xiaolu Xiong & Wenhui Yang. (2022) Complete Protection Against Yersinia pestis in BALB/c Mouse Model Elicited by Immunization With Inhalable Formulations of rF1-V10 Fusion Protein via Aerosolized Intratracheal Inoculation. Frontiers in Immunology 13.
Crossref
K. M. Korytov, V. I. Dubrovina, V. V. Voytkova, A. B. Pyatidesyatnikova, E. A. Glushkov, I. S. Akimova, N. V. Ondar, L. K. Salchak, A. A. Saydy, Yu. K. Orteney & S. V. Balakhonov. (2021) Efficiency of human plague vaccination in tuvinian natural plague focus. Message 2: dynamics of immune status indicators after revaccination. Acta Biomedica Scientifica 6:5, pages 44-56.
Crossref
Raysa Rosario-Acevedo, Sergei S. Biryukov, Joel A. Bozue & Christopher K. Cote. (2021) Plague Prevention and Therapy: Perspectives on Current and Future Strategies. Biomedicines 9:10, pages 1421.
Crossref
Nilüfer GÜN. (2021) Brief overview of anthrax vaccines: Current and future developments. International Journal of Life Sciences and Biotechnology.
Crossref
J. Conlan, Anders Sjöstedt, H. Gelhaus, Perry Fleming, Kevan McRae, Ronald Cobb, Roberto De Pascalis & Karen Elkins. (2021) Modern Development and Production of a New Live Attenuated Bacterial Vaccine, SCHU S4 ΔclpB, to Prevent Tularemia. Pathogens 10:7, pages 795.
Crossref
Jason A. Rosenzweig, Emily K. Hendrix & Ashok K. Chopra. (2021) Plague vaccines: new developments in an ongoing search. Applied Microbiology and Biotechnology 105:12, pages 4931-4941.
Crossref
Zahra Raahati, Bita Bakhshi & Shahin Najar-peerayeh. (2020) Selenium Nanoparticles Induce Potent Protective Immune Responses against Vibrio cholerae WC Vaccine in a Mouse Model. Journal of Immunology Research 2020, pages 1-12.
Crossref
Valentina A. Feodorova, Anna M. Lyapina, Maria A. Khizhnyakova, Sergey S. Zaitsev, Yury V. Saltykov & Vladimir L. Motin. (2020) Yersinia pestis Antigen F1 but Not LcrV Induced Humoral and Cellular Immune Responses in Humans Immunized with Live Plague Vaccine—Comparison of Immunoinformatic and Immunological Approaches. Vaccines 8:4, pages 698.
Crossref
Florent Sebbane, Vladimir N. Uversky & Andrey P. Anisimov. (2020) Yersinia pestis Plasminogen Activator. Biomolecules 10:11, pages 1554.
Crossref
Xavier Vallès, Nils Chr. Stenseth, Christian Demeure, Peter Horby, Paul S. Mead, Oswaldo Cabanillas, Mahery Ratsitorahina, Minoarisoa Rajerison, Voahangy Andrianaivoarimanana, Beza Ramasindrazana, Javier Pizarro-Cerda, Holger C. Scholz, Romain Girod, B. Joseph Hinnebusch, Ines Vigan-Womas, Arnaud Fontanet, David M. Wagner, Sandra Telfer, Yazdan Yazdanpanah, Pablo Tortosa, Guia Carrara, Jane Deuve, Steven R. Belmain, Eric D’Ortenzio & Laurence Baril. (2020) Human plague: An old scourge that needs new answers. PLOS Neglected Tropical Diseases 14:8, pages e0008251.
Crossref
Adam Clark & Daniel N. Wolfe. (2020) Current State of Anthrax Vaccines and Key R&D Gaps Moving Forward. Microorganisms 8:5, pages 651.
Crossref
K. M. Korytov, V. V. Voitkova, V. I. Dubrovina, A. B. Pyatidesyatnikova, A. K. Noskov, E. A. Glushkov, I. S. Akimova, N. V. Ondar, L. K. Salchak, O. S. Mongush, A. D. Dazhikay, A. A. Saydy, Yu. K. Orteney & S. V. Balakhonov. (2019) Efficiency of Human Plague Vaccination in Tuvinian Natural Plague Focus. Acta Biomedica Scientifica (East Siberian Biomedical Journal) 4:5, pages 31-37.
Crossref
E D Williamson & G E Westlake. (2019) Vaccines for emerging pathogens: prospects for licensure. Clinical and Experimental Immunology 198:2, pages 170-183.
Crossref
Zaurbek Sagiyev, Almas Berdibekov, Tatyana Bolger, Almagul Merekenova, Svetlana Ashirova, Zamir Nurgozhin & Zhandos Dalibayev. (2019) Human response to live plague vaccine EV, Almaty region, Kazakhstan, 2014-2015. PLOS ONE 14:6, pages e0218366.
Crossref
Stephen T. Smiley, Frank M. Szaba, Lawrence W. Kummer, Debra K. Duso & Jr-Shiuan Lin. (2019) Yersinia pestis Pla Protein Thwarts T Cell Defense against Plague . Infection and Immunity 87:5.
Crossref
Feodorova, Lyapina, Zaitsev, Khizhnyakova, Sayapina, Ulianova, Ulyanov & Motin. (2019) New Promising Targets for Synthetic Omptin-Based Peptide Vaccine against Gram-Negative Pathogens. Vaccines 7:2, pages 36.
Crossref
K. M. Korytov, V. V. Voitkova, V. I. Dubrovina, A. K. Noskov, A. I. Mishchenko, E. P. Mikhailov, S. V. Balakhonov & L. V. Schuchinov. (2019) Immunological Efficiency of Human Plague Vaccination in the Gorno-Altai High-Mountain Natural Plague Focus. Epidemiology and Vaccine Prevention 17:6, pages 87-97.
Crossref
Nittaya Khakhum, Daniel Tapia & Alfredo G. Torres. 2019. Defense Against Biological Attacks. Defense Against Biological Attacks 161 183 .
E. D’Ortenzio, N. Lemaître, C. Brouat, P. Loubet, F. Sebbane, M. Rajerison, L. Baril & Y. Yazdanpanah. (2018) Plague: Bridging gaps towards better disease control. Médecine et Maladies Infectieuses 48:5, pages 307-317.
Crossref
Valentina A. Feodorova, Anna M. Lyapina, Maria A. Khizhnyakova, Sergey S. Zaitsev, Lidiya V. Sayapina, Tatiana E. Arseneva, Alexey L. Trukhachev, Svetlana A. Lebedeva, Maxim V. Telepnev, Onega V. Ulianova, Elena P. Lyapina, Sergey S. Ulyanov & Vladimir L. Motin. (2018) Humoral and cellular immune responses to Yersinia pestis Pla antigen in humans immunized with live plague vaccine. PLOS Neglected Tropical Diseases 12:6, pages e0006511.
Crossref
Piotr Cieślik, Józef Knap & Agata Bielawska-Drózd. (2018) FRANCISELLA TULARENSIS – REVIEW . Postępy Mikrobiologii - Advancements of Microbiology 57:1, pages 58-67.
Crossref
Christian E. Demeure, Anne Derbise & Elisabeth Carniel. (2017) Oral vaccination against plague using Yersinia pseudotuberculosis. Chemico-Biological Interactions 267, pages 89-95.
Crossref
Alicia Y. Chou, Nikki J. Kennett, Amanda A. Melillo & Karen L. Elkins. (2017) Murine survival of infection with Francisella novicida and protection against secondary challenge is critically dependent on B lymphocytes. Microbes and Infection 19:2, pages 91-100.
Crossref
Shailendra Kumar Verma & Urmil Tuteja. (2016) Plague Vaccine Development: Current Research and Future Trends. Frontiers in Immunology 7.
Crossref
M. Zamri-Saad & M.I. Kamarudin. (2016) Control of animal brucellosis: The Malaysian experience. Asian Pacific Journal of Tropical Medicine 9:12, pages 1136-1140.
Crossref
Thomas R. Laws, Tinatin Kuchuloria, Nazibriola Chitadze, Stephen F. Little, Wendy M. Webster, Amanda K. Debes, Salome Saginadze, Nikoloz Tsertsvadze, Mariam Chubinidze, Robert G. Rivard, Shota Tsanava, Edward H. Dyson, Andrew J. H. Simpson, Matthew J. Hepburn & Nino Trapaidze. (2016) A Comparison of the Adaptive Immune Response between Recovered Anthrax Patients and Individuals Receiving Three Different Anthrax Vaccines. PLOS ONE 11:3, pages e0148713.
Crossref
Valentina A. Feodorova, Lidiya V. Sayapina & Vladimir L. Motin. 2016. Vaccine Design. Vaccine Design 487 498 .
Amit K. Singh, Joseph J. Kingston, Shishir K. Gupta & Harsh V. Batra. (2015) Recombinant Bivalent Fusion Protein rVE Induces CD4+ and CD8+ T-Cell Mediated Memory Immune Response for Protection Against Yersinia enterocolitica Infection. Frontiers in Microbiology 6.
Crossref
Bethany L. Tiner, Jian Sha, Duraisamy Ponnusamy, Wallace B. Baze, Eric C. Fitts, Vsevolod L. Popov, Christina J. van Lier, Tatiana E. Erova & Ashok K. Chopra. (2015) Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague. Clinical and Vaccine Immunology 22:12, pages 1255-1268.
Crossref